Literature DB >> 7526872

Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen.

X Shi-Wen1, M Panesar, R Vancheeswaran, J Mason, D Haskard, C Black, I Olsen, D Abraham.   

Abstract

OBJECTIVE: To examine intercellular adhesion molecule 1 (ICAM-1) and lymphocyte function-associated antigen 3 (LFA-3) in cultures of normal and systemic sclerosis (SSc) dermal fibroblasts.
METHODS: The surface and soluble forms of ICAM-1 and LFA-3 were measured by flow cytometry and capture enzyme-linked immunosorbent assay, respectively.
RESULTS: Surface ICAM-1 was significantly higher on SSc fibroblasts compared with normal controls. Beta-estradiol did not directly enhance ICAM-1 or LFA-3 expression in either normal or SSc cells, but significantly augmented the cytokine-induced increase in ICAM-1. Soluble ICAM-1 (sICAM-1) and sLFA-3 were detected in fibroblast cultures. While no difference was found in the level of sLFA-3, the shedding of sICAM-1 was significantly increased (P < 0.001) in cells from SSc patients.
CONCLUSION: SSc fibroblasts express intrinsically elevated levels of surface ICAM-1 and release higher levels of sICAM-1 in vitro. Increased expression of ICAM-1 by interferon-gamma and tumor necrosis factor alpha alone, and the further induction in combination with beta-estradiol may underlie an aspect of fibroblast dysfunction in SSc and the female predisposition to the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526872     DOI: 10.1002/art.1780371119

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.

Authors:  P P Sfikakis; G C Tsokos
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation.

Authors:  Ann E Brannigan; R William G Watson; David Beddy; Hilary Hurley; John M Fitzpatrick; P Ronan O'Connell
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

Review 4.  Novel therapeutic strategies in scleroderma.

Authors:  C P Denton; C M Black
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

5.  Prediction of residual valvular lesions in rheumatic heart disease: role of adhesion molecules.

Authors:  Mona Hafez; Sohier Yahia; Waleed Eldars; Heba Eldegla; Mohamed Matter; Gehan Attia; Samia Hawas
Journal:  Pediatr Cardiol       Date:  2012-09-18       Impact factor: 1.655

6.  Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations.

Authors:  Heloisa Helena Braga Sawaya; Romy Beatriz Christmann de Souza; Solange Carrasco; Claudia Goldenstein-Schainberg
Journal:  Clin Rheumatol       Date:  2009-02-19       Impact factor: 2.980

7.  Autoantibodies to estrogen receptor α in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression.

Authors:  Antonello Giovannetti; Angela Maselli; Tania Colasanti; Edoardo Rosato; Felice Salsano; Simonetta Pisarri; Ivano Mezzaroma; Walter Malorni; Elena Ortona; Marina Pierdominici
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

8.  Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins.

Authors:  Edward P Stern; Robert Unwin; Aine Burns; Voon H Ong; Christopher P Denton
Journal:  Rheumatol Adv Pract       Date:  2021-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.